Invention Grant
- Patent Title: Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
-
Application No.: US15647257Application Date: 2017-07-11
-
Publication No.: US10294208B2Publication Date: 2019-05-21
- Inventor: Helmut Schickaneder , Christian Schickaneder , Armin Buschauer , Stefan Huber , Michael Limmert , Günther Bernhardt , Mathias Lubbe , Harald Hofmeier
- Applicant: Helmut Schickaneder
- Applicant Address: CH Schaffhausen
- Assignee: SYNBIAS PHARMA AG
- Current Assignee: SYNBIAS PHARMA AG
- Current Assignee Address: CH Schaffhausen
- Agency: Potomac Law Group, PLLC
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; C07D235/16 ; C07C231/02
Abstract:
The present invention relates to bendamustine derivatives and related compounds of formula (VII), (VIII) and (IX), and medical uses thereof in particular in cancer therapy.
Public/Granted literature
- US20170313663A1 Bendamustine Derivatives and Related Compounds, and Medical Use Thereof in Cancer Therapy Public/Granted day:2017-11-02
Information query
IPC分类:
